• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因低甲基化是男性和女性原发性骨质疏松症的一个新的潜在生物标志物。

Hypomethylation of the Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women.

机构信息

Endocrinology Research Centre, Dmitriya Ulianova Street, 11, 117036 Moscow, Russia.

Internal Medicine & Clinical Psychology Department, Bashkir State Medical University, 450008 Ufa, Russia.

出版信息

Int J Mol Sci. 2024 Jul 3;25(13):7312. doi: 10.3390/ijms25137312.

DOI:10.3390/ijms25137312
PMID:39000419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11242095/
Abstract

The search for the molecular markers of osteoporosis (OP), based on the analysis of differential deoxyribonucleic acid (DNA) methylation in bone cells and peripheral blood cells, is promising for developments in the field of the early diagnosis and targeted therapy of the disease. The Runt-related transcription factor 2 () gene is one of the key genes of bone metabolism, which is of interest in the search for epigenetic signatures and aberrations associated with the risk of developing OP. Based on pyrosequencing, the analysis of the methylation profile from a pool of peripheral blood cells in men and women over 50 years of age of Russian ethnicity from the Volga-Ural region of Russia was carried out. The level of DNA methylation in three CpG sites of the gene was assessed and statistically significant hypomethylation was revealed in all three studied CpG sites in men (U = 746.5, = 0.004; U = 784, = 0.01; U = 788.5, = 0.01, respectively) and in one CpG site in women (U = 537, = 0.03) with primary OP compared with control. In the general sample, associations were preserved for the first CpG site (U = 2561, = 0.0001766). The results were obtained for the first time and indicate the existence of potentially new epigenetic signatures of in individuals with OP.

摘要

基于对骨细胞和外周血细胞中差异脱氧核糖核酸(DNA)甲基化的分析,寻找骨质疏松症(OP)的分子标志物,这对于疾病的早期诊断和靶向治疗领域的发展是有希望的。Runt 相关转录因子 2()基因是骨代谢的关键基因之一,在寻找与 OP 发病风险相关的表观遗传特征和异常方面引起了关注。基于焦磷酸测序,对来自俄罗斯伏尔加-乌拉尔地区的 50 岁以上俄罗斯男性和女性外周血细胞池的甲基化谱进行了分析。评估了 基因三个 CpG 位点的 DNA 甲基化水平,在男性的所有三个研究 CpG 位点(U = 746.5, = 0.004;U = 784, = 0.01;U = 788.5, = 0.01,分别)和女性的一个 CpG 位点(U = 537, = 0.03)中发现与原发性 OP 相比,所有三个 CpG 位点的 DNA 甲基化水平均显著降低。在一般样本中,与第一个 CpG 位点(U = 2561, = 0.0001766)保持关联。这些结果是首次获得的,表明存在 OP 个体中潜在的新 基因的表观遗传特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/01af679e2122/ijms-25-07312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/b3ba6b75bc28/ijms-25-07312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/6dc543af7a68/ijms-25-07312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/cb15955dd560/ijms-25-07312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/01af679e2122/ijms-25-07312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/b3ba6b75bc28/ijms-25-07312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/6dc543af7a68/ijms-25-07312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/cb15955dd560/ijms-25-07312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8836/11242095/01af679e2122/ijms-25-07312-g004.jpg

相似文献

1
Hypomethylation of the Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women.基因低甲基化是男性和女性原发性骨质疏松症的一个新的潜在生物标志物。
Int J Mol Sci. 2024 Jul 3;25(13):7312. doi: 10.3390/ijms25137312.
2
Identification of an Epigenetic Signature of Osteoporosis in Blood DNA of Postmenopausal Women.绝经后妇女血液 DNA 中骨质疏松症的表观遗传特征鉴定。
J Bone Miner Res. 2018 Nov;33(11):1980-1989. doi: 10.1002/jbmr.3527. Epub 2018 Jul 20.
3
[Methylation of CpG island in promoter region of RUNX2 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].RUNX2基因启动子区域CpG岛甲基化及其在HOX11(+)急性T淋巴细胞白血病中的表达
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):273-8. doi: 10.7534/j.issn.1009-2137.2013.02.003.
4
Primary Osteoporosis Is Not Reflected by Disease-Specific DNA Methylation or Accelerated Epigenetic Age in Blood.原发性骨质疏松症在血液中并未反映出疾病特异性的 DNA 甲基化或加速的表观遗传年龄。
J Bone Miner Res. 2018 Feb;33(2):356-361. doi: 10.1002/jbmr.3298. Epub 2017 Oct 23.
5
Epigenetic regulation of BMP2 gene in osteoporosis: a DNA methylation study.骨质疏松症中BMP2基因的表观遗传调控:一项DNA甲基化研究
Mol Biol Rep. 2019 Apr;46(2):1667-1674. doi: 10.1007/s11033-019-04615-y. Epub 2019 Feb 20.
6
Hypomethylation of Alu elements in post-menopausal women with osteoporosis.绝经后骨质疏松症妇女中 Alu 元件的低甲基化。
PLoS One. 2013 Aug 21;8(8):e70386. doi: 10.1371/journal.pone.0070386. eCollection 2013.
7
Differences of RUNX2 gene promoter methylation and transcription level in ankylosing spondylitis.强直性脊柱炎中 RUNX2 基因启动子甲基化和转录水平的差异。
Int J Rheum Dis. 2023 Dec;26(12):2526-2533. doi: 10.1111/1756-185X.14955. Epub 2023 Oct 30.
8
The Polymorphism at PLCB4 Promoter (rs6086746) Changes the Binding Affinity of RUNX2 and Affects Osteoporosis Susceptibility: An Analysis of Bioinformatics-Based Case-Control Study and Functional Validation.PLCB4 启动子(rs6086746)多态性改变 RUNX2 的结合亲和力并影响骨质疏松易感性:基于生物信息学的病例对照研究和功能验证分析。
Front Endocrinol (Lausanne). 2021 Nov 25;12:730686. doi: 10.3389/fendo.2021.730686. eCollection 2021.
9
DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes.RUNX2 P1 启动子的 DNA 甲基化介导软骨细胞中 MMP13 的转录。
Sci Rep. 2017 Aug 10;7(1):7771. doi: 10.1038/s41598-017-08418-8.
10
Epigenetic age signatures in bones.骨中的表观遗传年龄特征。
Forensic Sci Int Genet. 2020 May;46:102261. doi: 10.1016/j.fsigen.2020.102261. Epub 2020 Feb 9.

引用本文的文献

1
Epigenetic Modulation and Bone Metastasis: Evolving Therapeutic Strategies.表观遗传调控与骨转移:不断发展的治疗策略
Pharmaceuticals (Basel). 2025 Jul 31;18(8):1140. doi: 10.3390/ph18081140.
2
Serum LCAT as a Gender-Neutral Biomarker for Early Osteoporosis: A Multicenter Cohort Validation Study.血清卵磷脂胆固醇酰基转移酶作为早期骨质疏松症的性别中性生物标志物:一项多中心队列验证研究。
Int J Gen Med. 2025 Jul 31;18:4131-4145. doi: 10.2147/IJGM.S536568. eCollection 2025.

本文引用的文献

1
Peak Bone Mass Formation: Modern View of the Problem.峰值骨量形成:该问题的现代观点
Biomedicines. 2023 Nov 6;11(11):2982. doi: 10.3390/biomedicines11112982.
2
Differences of RUNX2 gene promoter methylation and transcription level in ankylosing spondylitis.强直性脊柱炎中 RUNX2 基因启动子甲基化和转录水平的差异。
Int J Rheum Dis. 2023 Dec;26(12):2526-2533. doi: 10.1111/1756-185X.14955. Epub 2023 Oct 30.
3
Getting personal with epigenetics: towards individual-specific epigenomic imputation with machine learning.深入了解表观遗传学:利用机器学习进行个体化特异性表观基因组推断。
Nat Commun. 2023 Aug 7;14(1):4750. doi: 10.1038/s41467-023-40211-2.
4
Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis.骨重塑的表观遗传调控及其在原发性骨质疏松症发病机制中的作用。
Vavilovskii Zhurnal Genet Selektsii. 2023 Jul;27(4):401-410. doi: 10.18699/VJGB-23-48.
5
RUNX2 and Cancer.RUNX2 与癌症。
Int J Mol Sci. 2023 Apr 10;24(8):7001. doi: 10.3390/ijms24087001.
6
Comprehensive analysis of epigenetics mechanisms in osteoporosis.骨质疏松症表观遗传机制的综合分析
Front Genet. 2023 Mar 28;14:1153585. doi: 10.3389/fgene.2023.1153585. eCollection 2023.
7
A Mini Review on Osteoporosis: From Biology to Pharmacological Management of Bone Loss.骨质疏松症综述:从生物学机制到骨质流失的药物治疗
J Clin Med. 2022 Oct 30;11(21):6434. doi: 10.3390/jcm11216434.
8
Using a Polygenic Score to Predict the Risk of Developing Primary Osteoporosis.使用多基因风险评分预测原发性骨质疏松症的发病风险。
Int J Mol Sci. 2022 Sep 2;23(17):10021. doi: 10.3390/ijms231710021.
9
Current Status of the Diagnosis and Management of Osteoporosis.骨质疏松症的诊断与管理现状。
Int J Mol Sci. 2022 Aug 21;23(16):9465. doi: 10.3390/ijms23169465.
10
The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019.204 个国家和地区 1990-2019 年骨质疏松症、低骨量及其相关骨折的全球负担
Front Endocrinol (Lausanne). 2022 May 20;13:882241. doi: 10.3389/fendo.2022.882241. eCollection 2022.